Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2025
Effectiveness of Nicotine Replacement Therapy and Behavioral Intervention in Tobacco Cessation-A Tertiary Hospital-Based Randomized Controlled Trial.
Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Narrative Review of Novel Nicotine-Delivery Systems and Emerging Pharmaceuticals for Tobacco Cessation.Medicines (Basel, Switzerland) · 2026Review
- Oral premalignant disorders in housekeeping and security staff of a higher education institute in Bhubaneshwar, Odisha state, India.Journal of family medicine and primary care · 2026Article
- Cessation at the Core: India's Fight Against Tobacco in the Next Decade.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe effectiveness of nicotine replacement therapy (NRT) on smokeless tobacco (SLT) users is underexplored in India, with prior research primarily focusing on smokers. This study assessed and compared the effectiveness of combining behavioral intervention (BI) and NRT with BI alone on smoking and SLT cessation.
methodsThis 1.5-year prospective, open-label, three-arm parallel-group randomized controlled trial was conducted at the Tobacco Cessation Clinic, SCB Dental College and Hospital, Odisha, India. The three intervention groups-BI, BI + nicotine patch, and BI + nicotine gum-were assessed using a prevalidated proforma on sociodemographics, relevant medical and dental history, oral hygiene practices, and previous tobacco use patterns.
resultsThe study enrolled 130 participants. At 26 weeks, 63.3% (19/30) in the BI + patch and 52.9% (18/34) in the BI + gum achieved abstinence, compared to 24.1% (7/29) in the BI group. The odds ratio (OR), 95% confidence interval (CI); p-value of abstinence was 6.03 (1.90-19.15; p = .003) for BI + patch, and 3.25 (1.08-9.78; p = .035) for BI + gum. Among SLT users, abstinence was achieved in 70.59% (12/17) with BI + patch (OR 6.40, 95% CI: 1.57-26.03; p = .010) and 53.85% (14/26) with BI + gum (OR 3.11, 95% CI: .92-10.47; p = .067) versus 27.27% (6/22) with BI alone. Both intervention groups demonstrated significantly reduced relapse risk versus BI alone (Hazard ratio [HR] 0.45, 95% CI: .24-.83; p = .011) for BI + patch and HR 0.40, 95% CI: .22-.74; p = .003 for BI + gum.
conclusionCombination therapy (BI + NRT) is more effective than BI alone. The BI + patch combination is more effective than BI + gum and BI alone. The NRT intervention groups had higher abstinence rates and reduced relapses than the standard BI group. Further studies are required to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.